Related Experiment Video

Updated: Oct 13, 2025

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

12.6K

Bladder cancer risk variants and overall and disease-specific survival in two independent cohorts

Reno C Leeming1, Margaret R Karagas1, Michael S Zens1

  • 1Department of Epidemiology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.

BJU International
|November 14, 2021
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Culture of Bladder Cancer Organoids as Precision Medicine Tools
08:39

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Published on: December 28, 2021

4.9K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

421

Related Experiment Videos

Last Updated: Oct 13, 2025

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

12.6K
Culture of Bladder Cancer Organoids as Precision Medicine Tools
08:39

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Published on: December 28, 2021

4.9K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

421

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

478
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
478

Articles linked to this work by shared authors, journal, and citation graph.

Beyond the bladder: case series of Mycobacterium bovis bacillus Calmette-Guérin infections following intravesical instillation.

ASM case reports·2026

Retroelement Hypomethylation Links Hypoxia Signaling, Immune Phenotypes, and Survival in Clear Cell Renal Cell Carcinoma.

bioRxiv : the preprint server for biology·2026

Characterizing Symptoms and Defining Toxicity in Ambulatory Transurethral Resection of Bladder Tumor: Results From a Multicenter Prospective Cohort Study.

Urology·2025

Matched analysis of detailed peripheral blood and tumor immune microenvironment profiles in bladder cancer.

Epigenomics·2024

Genome-Scale Methylation Analysis Identifies Immune Profiles and Age Acceleration Associations with Bladder Cancer Outcomes.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2023

Initial Experience of Magnetic Resonance Imaging Fusion Biopsy in the Community Setting.

Urology practice·2023

Real-world radical cystectomy use in high-risk non-muscle-invasive bladder cancer: a global survey.

BJU international·2026

Sexual and relational challenges in men and women affected by prostate cancer: a Project SEXUS study.

BJU international·2026

The PSA test for prostate cancer screening: an abridged Cochrane review.

BJU international·2026

Three-generation familial risks in early-onset prostate cancer with maternal and paternal relatives.

BJU international·2026

Towards sustainable multidisciplinary renal cancer tumour boards: redesigning the referral pathway.

BJU international·2026

Oncological and continence outcomes after nerve-sparing robot-assisted radical prostatectomy in selected STAMPEDE-defined high-risk prostate cancer.

BJU international·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us